Literature DB >> 10404371

Comparison of the effects of viscoelastic agents on clinical properties of the Unfolder lens injection system.

T D Myers1, R J Olson.   

Abstract

PURPOSE: To evaluate the effect of 7 viscoelastic materials on the physical properties of the Unfolder lens injection system.
SETTING: John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, Utah, USA.
METHODS: New sterile SI-40NB intraocular lenses (IOLs) were loaded into the Unfolder (AMO PhacoFlex II SofTip insertion system (Allergan) using 7 viscoelastic materials: sodium hyaluronate 1.0% (Healon, Provisc), sodium hyaluronate 1.4% (Healon GV), sodium hyaluronate 1.6% (Amvisc Plus), hydroxypropyl methylcellulose 2.0% (Occucoat), sodium chondroitin 4.0%--sodium hyaluronate 3.0% (Viscoat), and hyaluronate 3.0% (Vitrax). The IOLs were then injected after 10 or 120 seconds in the chamber (chamber dwell time) and 10, 60, or 180 seconds in the barrel of the Unfolder cartridge (barrel dwell time). Torque values (g/cm) required to extrude the lenses were measured with a torque gauge, and the cartridges and IOLs were inspected for damage.
RESULTS: Longer chamber dwell times resulted in lower torque values to extrude the IOLs (P < .001). Conversely, longer barrel dwell times resulted in higher torque requirements for IOL extrusion (P < .001). Furthermore, rates of adverse events, such as nondelivery, IOL damage, or Unfolder cartridge damage, were higher with shorter chamber dwell times and longer barrel dwell times (P < .001). However, IOL damage was avoided when the manufacturer's recommended chamber and barrel times were used.
CONCLUSION: Increasing chamber dwell time and decreasing barrel dwell time resulted in lower torque values to extrude IOLs from the Unfolder and increased successful use. Moreover, dispersive viscoelastic agents tended to be more forgiving of changing dwell times and therefore had lower torque values and adverse event rates overall.

Mesh:

Substances:

Year:  1999        PMID: 10404371     DOI: 10.1016/s0886-3350(99)00085-1

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  The course of surface deposits on a hydrophilic acrylic intraocular lens after implantation through a hexagonal cartridge.

Authors:  A L Marcovich; G Kleinmann; D Epstein; A Pollack
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

2.  Rotational stability of Toric intraocular lenses.

Authors:  Abhinav Singh; Gaurav Kapoor; Vinod K Baranwal; Nidhi Kalra
Journal:  Med J Armed Forces India       Date:  2020-07-09

3.  Propensity-matched comparison of postoperative stability and visual outcomes of toric intraocular lens with or without a capsular tension ring and updated meta-analysis.

Authors:  Dongmei Ma; Xiaoyan Han; Zhixiang Hua; Jiying Shen; Limei Zhang; Tian Qiu; Jianfeng Luo; Lei Cai; Jin Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-06       Impact factor: 3.535

4.  Toric Intraocular Lens for Astigmatism Correction in Cataract Patients.

Authors:  Hassan Razmjoo; Mohammad Ghoreishi; Azadeh Mohammadi Milasi; Alireza Peyman; Zahra Jafarzadeh; Mohadeseh Mohammadinia; Nasrollahi Kobra
Journal:  Adv Biomed Res       Date:  2017-10-16

5.  Visual outcome and refractive status with monofocal toric intraocular lens implantation to correct astigmatism during cataract surgery.

Authors:  Mayuri Sh Patil; Archana S Nikose; Shadwala Bharti
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

6.  A laboratory evaluation of nozzle tip damage in four generations of intraocular lens injector systems using a self-developed damage scale.

Authors:  Hui Fang; Lu Zhang; Sonja Schickhardt; Patrick R Merz; Weijia Yan; Mélanie Leroux; Gerd U Auffarth
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

7.  Comparative evaluation of rotational stability and visual outcome of toric intraocular lenses with and without a capsular tension ring.

Authors:  Anju Rastogi; Samreen Khanam; Yashpal Goel; Prolima Thacker; Prateek Kumar
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.